Ilse Roodink
Chief Tech/Sci/R&D Officer bei IMMUNOPRECISE ANTIBODIES LTD.
Vermögen: 14 504 $ am 31.03.2024
Profil
Ilse Roodink is currently the Chief Scientific Officer at ImmunoPrecise Antibodies Ltd.
She previously worked as the Scientific Director at Immunoprecise Antibodies (Europe) BV.
Dr. Roodink received her undergraduate, graduate, and doctorate degrees from Radboud University Nijmegen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 9 542 ( 0,04% ) | 14 504 $ | 31.03.2024 |
Aktive Positionen von Ilse Roodink
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Chief Tech/Sci/R&D Officer | 01.07.2021 |
Ehemalige bekannte Positionen von Ilse Roodink
| Unternehmen | Position | Ende |
|---|---|---|
Immunoprecise Antibodies (Europe) BV
 Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Ilse Roodink
| Radboud University Nijmegen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Health Technology |
